Infinium Pharmachem
add_icon

Infinium Pharmachem

209.75
0.00
(0.00%)
Market Cap
326.86 Cr
PE Ratio
41.70
Volume
0.00
Day High - Low
- - -
52W High-Low
337.00 - 202.05
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
326.86 Cr
EPS
5.60
PE Ratio
41.70
PB Ratio
2.97
Book Value
70.25
EBITDA
18.50
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
6.28
Debt to Equity
0.38
Forecast For
Actual

Company News

View All News
Caret
positive
Infinium Pharmachem starts new manufacturing facility for contrast media raw materials, targeting ₹100 crore annual revenue from the expanded production capacity.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,773.40
#1 4,25,498.06
38.32
#1 54,729.00
9.71
#1 10,980
16.07
57.99
6,363.00
1,68,917.66
67.46
9,712.00
18.67
2,191
-1.02
52.22
4,337.40
1,46,797.33
64.68
11,539.40
6.99
1,911
26.24
63.94
1,305.70
1,08,977.69
19.51
33,741.20
16.73
5,725
-15.28
56.51
2,349.70
1,07,334.02
22.56
22,909.50
13.74
3,306
#1 37.44
66.34
1,322.10
1,06,795.51
23.39
28,409.50
7.12
5,291
-57.18
38.47
2,222.30
91,737.67
50.48
12,744.20
#1 20.90
2,007
7.65
58.19
905.30
91,094.36
#1 17.95
23,511.00
18.55
4,615
-0.32
46.68
1,208.10
70,166.64
19.92
32,345.60
9.43
3,484
7.59
52.73
5,503.00
65,796.62
26.96
13,458.30
3.70
2,216
1.90
43.53
Growth Rate
Revenue Growth
15.01 %
Net Income Growth
-32.17 %
Cash Flow Change
-123.31 %
ROE
-67.12 %
ROCE
-55.79 %
EBITDA Margin (Avg.)
-19.75 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
39
71
100
116
137
158
0
Expenses
36
66
89
98
117
139
0
EBITDA
3
6
11
17
20
19
0
Operating Profit %
6 %
7 %
10 %
14 %
14 %
11 %
0 %
Depreciation
1
1
1
1
3
3
0
Interest
1
1
2
3
2
4
0
Profit Before Tax
1
4
9
13
15
12
0
Tax
0
1
2
3
4
4
0
Net Profit
1
3
7
10
12
8
0
EPS in ₹
9.19
26.80
60.07
6.82
8.12
5.60
0.00

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
22
34
59
71
86
198
Fixed Assets
4
5
4
19
20
24
Current Assets
18
26
44
51
65
140
Capital Work in Progress
0
4
9
0
0
1
Investments
0
0
0
0
0
29
Other Assets
18
26
46
52
66
144
Total Equity & Liabilities
22
34
59
71
86
198
Current Liabilities
12
21
32
37
17
64
Non Current Liabilities
6
6
14
10
8
10
Total Equity
4
7
14
24
60
125
Reserve & Surplus
3
6
12
18
45
94
Share Capital
1
1
1
5
14
16

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
1
4
1
6
23
Investing Activities
-1
-5
-7
-5
-4
-27
Operating Activities
3
7
12
9
-13
-29
Financing Activities
-1
-1
-2
-3
23
79

Share Holding

% Holding
Feb 2023
Mar 2023
Apr 2023
Sept 2023
Mar 2024
Sept 2024
Nov 2024
Mar 2025
Sept 2025
Promoter
100.00 %
100.00 %
73.05 %
73.05 %
73.05 %
73.05 %
65.24 %
65.24 %
59.91 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
22.56 %
23.96 %
23.85 %
23.97 %
32.05 %
32.00 %
37.21 %
Others
0.00 %
0.00 %
4.38 %
2.99 %
3.10 %
2.98 %
2.71 %
2.76 %
2.88 %
No of Share Holders
17
17
1,145
646
771
947
998
958
1,052

Technical Indicators

RSI(14)
Neutral
41.68
ATR(14)
Volatile
6.56
STOCH(9,6)
Neutral
21.07
STOCH RSI(14)
Oversold
14.51
MACD(12,26)
Bearish
-0.65
ADX(14)
Weak Trend
24.56
UO(9)
Bearish
44.89
ROC(12)
Downtrend And Accelerating
-3.98
WillR(14)
Neutral
-73.85